Page last updated: 2024-08-23

daunorubicin and Acquired Immune Deficiency Syndrome

daunorubicin has been researched along with Acquired Immune Deficiency Syndrome in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	13 (86.67)	18.2507
2000's	2 (13.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabriales, S; Espina, BM; Esplin, JA; Forssen, E; Gill, PS; Levine, AM; Liebman, HA; Muggia, F; Ross, ME; Tulpule, A	1
Dormann, A; Grünewald, T; Ruf, B; Schürmann, D	1
Blayney, DW; Flanagan, B; Kennedy, P; Lisak, J; Presant, CA; Presant, J; Scolaro, M	1
Bates, F; Boag, FC; Gazzard, BG; Money-Kyrle, JF; Phillips, RH; Ready, J	1
Cohen, P; Gill, PS; Gonzales, G; Jacobs, M; Kempin, S; Mukwaya, GM; Myers, AM; Pike, MC; Rarick, MU; Ross, ME; Sawka, C; Scadden, DT; Shepherd, F; Silverberg, I; von Roenn, JH; Wernz, J	1
Bouchaud, O; Eestermans, G; Girard, PM; Goetschel, A; Mukwaya, G; Ross, M; Rozenbaum, W; Saimot, AG	1
Aboulafia, DM; Bennett, CL; Bogner, J; Goebel, FD; Golub, RM; Stewart, S; Stinson, TJ; von Roenn, J	1
Boswell, W; Cabriales, S; Espina, BM; Gill, PS; Ilaw, M; Myers, A; Scadden, DT; Tulpule, A; Wernz, J; Yung, RC	1
Muggia, FM	1
Link, D	1
Cacoub, P; Poizot-Martin, I; Rosenthal, E; Saint-Marc, T; Spano, JP	1

Reviews

1 review(s) available for daunorubicin and Acquired Immune Deficiency Syndrome

Article	Year
Liposomal encapsulated anthracyclines: new therapeutic horizons. Current oncology reports, 2001, Volume: 3, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Liposomes; Lymphoma; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi	2001

Trials

8 trial(s) available for daunorubicin and Acquired Immune Deficiency Syndrome

Article	Year
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Daunorubicin; Drug Carriers; Female; Half-Life; Humans; Liposomes; Male; Middle Aged; Neutropenia; Prognosis; Remission Induction; Sarcoma, Kaposi; Survival Rate	1995
Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet (London, England), 1993, May-15, Volume: 341, Issue:8855 Topics: Acquired Immunodeficiency Syndrome; Adult; Daunorubicin; Drug Carriers; Humans; Liposomes; Lung Neoplasms; Pharyngeal Neoplasms; Quality of Life; Remission Induction; Sarcoma, Kaposi; Treatment Outcome	1993
Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study. Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Volume: 5, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia; Daunorubicin; Drug Carriers; Humans; Liposomes; Male; Middle Aged; Neutropenia; Recurrence; Sarcoma, Kaposi; Treatment Outcome	1993
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Adult; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Daunorubicin; Doxorubicin; Drug Carriers; Female; Humans; Liposomes; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Sarcoma, Kaposi; Survival Rate; Treatment Failure; United States; Vincristine	1996
Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma. AIDS (London, England), 1996, Volume: 10, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Daunorubicin; Disease Progression; Drug Carriers; Humans; Liposomes; Male; Middle Aged; Reaction Time; Remission Induction; Sarcoma, Kaposi	1996
Cost-effectiveness analysis comparing liposomal anthracyclines in the treatment of AIDS-related Kaposi's sarcoma. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Aug-15, Volume: 18, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Cost-Benefit Analysis; Daunorubicin; Decision Support Techniques; Doxorubicin; Drug Carriers; Humans; Liposomes; Sarcoma, Kaposi; Sensitivity and Specificity	1998
Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Administration Schedule; Humans; Liposomes; Lung; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Sarcoma, Kaposi; Survival Analysis	1998
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma. American journal of clinical oncology, 2002, Volume: 25, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antineoplastic; Antiretroviral Therapy, Highly Active; Daunorubicin; Female; Humans; Liposomes; Male; Middle Aged; Sarcoma, Kaposi	2002

Other Studies

6 other study(ies) available for daunorubicin and Acquired Immune Deficiency Syndrome

Article	Year
Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin. The European respiratory journal, 1994, Volume: 7, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Adult; Daunorubicin; Humans; Liposomes; Lung Neoplasms; Male; Radiography; Sarcoma, Kaposi	1994
Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Jul-01, Volume: 53, Issue:13 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Daunorubicin; Drug Approval; Drug Carriers; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1996
Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma. Prescrire international, 1998, Volume: 7, Issue:35 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Drug Evaluation; Humans; Liposomes; Sarcoma, Kaposi; Treatment Outcome; Vincristine	1998
DaunoXome offers KS treatment alternative. AIDS alert, 1996, Volume: 11, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Approval; Humans; Sarcoma, Kaposi; United States; United States Food and Drug Administration	1996
Liposomal KS drugs approved. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:4 Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Daunorubicin; Doxorubicin; Drug Carriers; Drug Costs; Humans; Liposomes; Sarcoma, Kaposi	1996
New York ADAP to cover new AIDS drugs plus viral load testing. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:9 Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antiviral Agents; Cytomegalovirus Infections; Daunorubicin; Drug Costs; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Insurance, Pharmaceutical Services; Lobbying; Nevirapine; New York; Pyridines; Sarcoma, Kaposi	1996